Intravenous Tolvaptan Sodium Phosphate Can Fail to Improve Fluid Overload Due to Heart Failure in Patients With Chronic Kidney Disease: A Case Report

ABSTRACT Tolvaptan is widely used as an adjunct oral diuretic to loop and thiazide diuretics for the management of fluid overload in patients with congestive heart failure. Recently, tolvaptan sodium phosphate (TSP), a water‐soluble prodrug of tolvaptan, was developed for intravenous administration...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Takaya Uno, Ichiro Nakakura, Akari Ikeda, Atsuki Hosoda, Yutaro Mukai, Kaori Yamanishi, Naohiro Ohara, Kaori Imanishi, Yoshiko Une, Satoshi Yokoyama, Kouichi Hosomi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-06-01
Colecção:	Pharmacology Research & Perspectives
Assuntos:	chronic kidney disease heart failure tolvaptan tolvaptan sodium phosphate
Acesso em linha:	https://doi.org/10.1002/prp2.70252
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!